Why is Aehr Test Systems (AEHR) stock up today?
Aehr Test Systems surged more than 21% after reporting a fiscal Q4 earnings beat and issuing a bullish forward outlook that lifted expectations for a demand recovery.
What happened
Aehr Test Systems jumped roughly 22% on July 15–16, 2026, closing near $87.79 after reaching an intraday high of $110.20, following the company's fiscal fourth-quarter earnings report. Quarterly earnings per share came in at $0.11, well ahead of the consensus estimate of -$0.0075, on revenue of $18.8 million. The beat-and-raise combination — strong current results paired with an upbeat forward outlook — sent the stock sharply higher as investors recalibrated expectations for a demand rebound.
The bullish guidance was the central driver of the rally. Coverage from Barchart described the move as a reaction to a 'beat-and-raise' report, while Insider Monkey noted that the bullish outlook was overshadowing what was otherwise a weak fiscal-year backdrop — revenue growth for the company stands at -43.7% year-over-year, underlining how far demand had fallen before this quarter's upside surprise. The magnitude of the earnings beat (profitable versus a near-breakeven estimate) signaled to the market that the worst of the downturn may be behind the company.
The broader semiconductor sector provided a mixed backdrop. The Nasdaq (tracked by QQQ) was down 0.27% on the day, and several larger chip names fell, suggesting AEHR's rally was driven entirely by its own earnings catalyst rather than sector tailwinds. ASML, a Dutch chip-equipment maker, did rise after reporting its own second-quarter beat and raising its forecast, which may have offered modest support to semiconductor equipment sentiment.
Despite the sharp single-day move, valuation questions linger in the analyst community. The stock carries a forward price-to-earnings (P/E) ratio of 88.7 and a market cap of approximately $2.85 billion. Simply Wall St. published analysis noting the stock looks strong on returns but overvalued relative to book value, and a separate piece asked whether the valuation gap after the earnings beat is 'too wide.' One analyst at SeekingAlpha set a $144 price target. As of this writing, Aehr Test shares trade at $87.79, well off the intraday high of $110.20, reflecting some intraday give-back after the initial surge.
The catalysts, cited
Aehr Test Systems reports fiscal Q4 EPS of $0.11 vs. estimate of -$0.0075, raises forward outlook
Barchart
Bullish guidance overshadows weak full-year earnings, driving the stock sharply higher
Insider Monkey
Motley Fool explains why Aehr Test Systems stock surged
Motley Fool
Valuation debate: Simply Wall St. calls stock overvalued on book value despite strong returns
Simply Wall St.
ASML rises on Q2 beat and raised forecast, offering broad semiconductor equipment backdrop
Investor's Business Daily
Why is ASML moving?
Why is NVDA moving?
Why is SMH moving?
Why is LRCX moving?People also ask
Why is Aehr Test Systems stock going up today?
Aehr Test Systems reported fiscal Q4 earnings of $0.11 per share, far above the consensus estimate of -$0.0075, on revenue of $18.8 million. The company also issued a bullish forward outlook, which led the market to sharply revise its expectations upward for a demand recovery.
What did AEHR report in earnings?
Aehr Test Systems beat both earnings and revenue estimates for its fiscal fourth quarter, posting EPS of $0.11 against an estimate of -$0.0075. Critically, the company also raised its forward outlook, which was described as a 'beat-and-raise' report by Barchart.
Is the whole chip sector up, or is it just AEHR?
The move appears specific to Aehr Test Systems. The Nasdaq (QQQ) was down 0.27% on the same day, and several larger chip names fell. ASML did rise after its own earnings beat, but the broader semiconductor sector was mixed, making AEHR's surge a company-specific event driven by its earnings catalyst.
Should I worry that AEHR stock is still well off its intraday high?
The stock reached an intraday high of $110.20 before pulling back to close near $87.79, a significant intraday reversal. Multiple analysts noted ongoing valuation concerns — the forward P/E stands at 88.7 and Simply Wall St. flagged the stock as overvalued relative to book value — which may explain why some of the early gains were given back during the session.